STUB1/CHIP Protein

📖 Wiki Page

protein1146 wordssynced 2026-04-02

STUB1/CHIP Protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">STUB1/CHIP Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>STUB1/CHIP</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>STUB1</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q9UNE7](https://www.uniprot.org/uniprot/Q9UNE7)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>34.6 kDa</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>305 amino acids</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Cytoplasm, Nucleus</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>U-box E3 ubiquitin ligase family</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>6p11.2</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Hsp90 inhibitor + CHIP</td>
<td>Geldanamycin analogs</td>
</tr>
<tr>
<td class="label">Hsp70 modulators</td>
<td>Apoptozole, YM-1</td>
</tr>
<tr>
<td class="label">Direct CHIP activation</td>
<td>Unknown</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-CHIP</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/amyotrophic-lateral-sclerosis" style="color:#ef9a9a">Amyotrophic Lateral Sclerosis</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/carcinoma" st

...

STUB1/CHIP Protein

Overview

STUB1/CHIP (STIP1 Homology And U-Box Containing Protein 1) is a 34.6 kDa U-box E3 ubiquitin ligase that serves as a critical nexus between molecular chaperones and the protein degradation machinery[@kakkar2014]. By simultaneously binding Hsp70/Hsp90 via its N-terminal tetratricopeptide repeat (TPR) domain and catalyzing ubiquitin transfer via its C-terminal U-box domain, CHIP coordinates the triage decision for misfolded proteins — either refolding, ubiquitinating for proteasomal degradation, or targeting for autophagic clearance[@ballinger2019].

CHIP is encoded by the [STUB1](/genes/stub1) gene on chromosome 6p11.2 and is ubiquitously expressed, with particularly high levels in the brain. As a central player in proteostasis, CHIP has been implicated in numerous neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, spinocerebellar ataxia, and hereditary spastic paraplegia[@tao2021].

Protein Information

Structure

CHIP possesses a bipartite domain architecture optimized for its dual role as cochaperone and E3 ligase:

N-terminal TPR Domain (residues 1-145):

Contains three tetratricopeptide repeat (TPR) motifs
Mediates high-affinity binding to Hsp70 and Hsp90 via their C-terminal EEVD motifs
Also interacts with other cochaperones including Hsp40, Hsp90 cochaperone p23
The TPR domain alone can suppress client protein aggregation in the absence of ligase activity

C-terminal U-box Domain (residues 227-305):

Characteristic E3 ubiquitin ligase fold resembling the RING finger
Catalyzes transfer of ubiquitin from E2 to substrate lysines
U-box architecture stabilized by hydrogen bonds rather than metal coordination (unlike RING fingers)
Confers ligase activity essential for proteasomal targeting

Central Linker Region (residues 146-226):

Contains a coiled-coil domain for homodimerization
CHIP functions as a homodimer, which is required for full E3 activity
Dimerization allows coordinated substrate handover between Hsp70/90 and the U-box

Normal Function

Protein Quality Control

CHIP functions as a triage manager for misfolded proteins, integrating chaperone and degradation pathways[@Connell2001]:

Recognition: CHIP recognizes Hsp70/Hsp90-client complexes via TPR domain binding

Handoff: Upon prolonged client misfolding, CHIP promotes client transfer from chaperones

Ubiquitination: CHIP catalyzes ubiquitin conjugation to exposed lysine residues on misfolded proteins

Degradation: Ubiquitinated clients are targeted to the 26S proteasome for degradation

Autophagy: In some contexts, CHIP also directs clients toward selective autophagy pathways

Chaperone Regulation

Beyond degradation, CHIP modulates chaperone function:

Dissociation: CHIP promotes release of clients from Hsp70/Hsp90 complexes
Cochaperone activity: The TPR domain itself can suppress aggregation independent of ligase activity
Regulation: CHIP expression is upregulated by heat shock factor 1 (HSF1) in response to proteotoxic stress

Autophagy and Mitophagy

CHIP directly regulates selective autophagy through multiple mechanisms[@shi2022]:

p62/SQSTM1 interaction: CHIP ubiquitinates substrates that are subsequently recognized by p62
Mitophagy: CHIP promotes清除 of damaged mitochondria via Parkin-dependent and independent pathways
Aggregate clearance: CHIP-targeted aggregates can be engulfed by autophagosomes

Role in Neurodegeneration

Alzheimer's Disease

CHIP influences multiple AD-relevant proteins:

Tau metabolism:

CHIP directly ubiquitinates hyperphosphorylated tau, promoting its proteasomal degradation
Loss of CHIP function leads to tau accumulation and aggregation
CHIP expression is reduced in AD brains, correlating with tau pathology
Genetic CHIP variants modify risk for tauopathies

APP and Aβ processing:

CHIP promotes lysosomal degradation of APP, reducing Aβ production
Hsp70/CHIP complexes can redirect APP from amyloidogenic to non-amyloidogenic pathways

Therapeutic implication: Enhancing CHIP activity could reduce both tau and Aβ burden simultaneously[@shi2024].

Parkinson's Disease

Alpha-synuclein clearance:

CHIP promotes polyubiquitination and degradation of α-synuclein
CHIP mutations are risk factors for PD susceptibility
Overexpression of CHIP reduces α-synuclein aggregation in cellular and animal models[@shi2022]

Mitophagy dysregulation:

CHIP cooperates with Parkin in removing damaged mitochondria
Impaired CHIP/Parkin mitophagy contributes to dopaminergic neuron vulnerability
Loss-of-function CHIP variants increase PD risk

Spinocerebellar Ataxia (SCA16 and SCA48)

Heterozygous mutations in [STUB1](/genes/stub1) cause SCA16 and SCA48[@jeong2023]:

Missense mutations in the U-box domain impair E3 ligase activity
Mutations act through dominant-negative mechanisms
Characterized by cerebellar ataxia, cognitive impairment, and pyramidal signs
Onset typically in adulthood, with progressive course

Hereditary Spastic Paraplegia (HSP)

Biallelic STUB1 mutations cause autosomal recessive HSP:

Presents with lower limb spasticity and hyperreflexia
Often accompanied by cognitive impairment
Mutations disrupt CHIP's ability to ubiquitinate client proteins

Amyotrophic Lateral Sclerosis (ALS)

CHIP levels are altered in ALS spinal motor neurons
CHIP dysfunction may contribute to TDP-43 and SOD1 aggregation
The protein quality control axis (Hsp70-CHIP-proteasome) is a therapeutic target

Mechanism of Action

Mermaid diagram (expand to render)

Therapeutic Approaches

CHIP Enhancers

Small molecule approaches to boost CHIP activity are under investigation[@shi2024]:

Challenges

Selectivity: CHIP has hundreds of substrates — global enhancement may cause toxicity

BBB penetration: Most small molecules don't cross the blood-brain barrier

Balance: Enhancing CHIP may promote degradation of beneficial proteins

Dimerization: CHIP requires homodimerization for activity — monomeric enhancers ineffective

Alternative Approaches

Hsp90 inhibitors (ganetespib, tanespimycin): Indirectly activate CHIP by destabilizing client proteins
Proteostasis network modulators: Target upstream chaperone systems
Combination therapy: CHIP enhancement + autophagy induction

Cross-Linking Relationships

[Hsp70](/proteins/hsp70) — Primary chaperone partner via TPR domain
[Hsp90](/proteins/hsp90) — Secondary chaperone partner
[p62/SQSTM1](/proteins/p62-protein) — Autophagy receptor for CHIP ubiquitinated substrates
[Parkin](/proteins/parkin-protein) — Cooperates in mitophagy
[VCP/p97](/proteins/vcp-protein) — Extracts ubiquitinated proteins from complexes

[Protein Quality Control](/mechanisms/protein-quality-control-network) — Core function
[Proteasomal Degradation](/mechanisms/proteasome-pathway) — Primary clearance route
[Autophagy-Lysosomal Pathway](/mechanisms/autophagy-lysosomal-pathway) — Alternative clearance
[Mitophagy](/mechanisms/mitophagy) — Mitochondrial quality control
[Unfolded Protein Response](/mechanisms/endoplasmic-reticulum-stress) — Cellular stress response

Disease Associations

[Alzheimer's Disease](/diseases/alzheimers-disease) — Tau and APP regulation
[Parkinson's Disease](/diseases/parkinsons-disease) — Alpha-synuclein, mitophagy
[Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia) — Direct genetic cause
[Hereditary Spastic Paraplegia](/diseases/hereditary-spastic-paraplegia) — Recessive mutations
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — TDP-43, SOD1 clearance

External Links

[UniProt: Q9UNE7](https://www.uniprot.org/uniprot/Q9UNE7)
[NCBI Gene: STUB1](https://www.ncbi.nlm.nih.gov/gene/10273)
[GeneCards: STUB1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=STUB1)
[Human Protein Atlas: STUB1](https://www.proteinatlas.org/ENSG00000103266-STUB1)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving STUB1/CHIP Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

STUB1/CHIP Protein

STUB1/CHIP Protein

Overview

STUB1/CHIP Protein

Overview

Protein Information

Structure

Normal Function

Protein Quality Control

Chaperone Regulation

Autophagy and Mitophagy

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Spinocerebellar Ataxia (SCA16 and SCA48)

Hereditary Spastic Paraplegia (HSP)

Amyotrophic Lateral Sclerosis (ALS)

Mechanism of Action

Therapeutic Approaches

CHIP Enhancers

Challenges

Alternative Approaches

Cross-Linking Relationships

Related Proteins

Related Pathways

Disease Associations

See Also

External Links

References

Pathway Diagram